» Articles » PMID: 31783076

Characterization of a Novel, Co-processed Bio-based Polymer, and Its Effect on Mucoadhesive Strength

Overview
Publisher Elsevier
Date 2019 Nov 30
PMID 31783076
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, a biological macromolecule obtained from seeds of Manilkara zapota was co-processed with hypromellose (cop-MPH)/sodium carboxymethylcellulose (cop-MPN)/polyvinylpyrrolidone (cop-MPP) in a 1:1 ratio and characterized for powder and mucoadhesive properties. The semi-crystalline nature of co-processed excipients and physical interaction between the component molecules were confirmed by X-ray diffraction and infrared spectroscopy analysis. The morphological study by scanning electron and atomic force microscopy showed spherical and polygonal-shaped particles with predominant smooth surfaces. Thermogravimetric analysis revealed thermal stability to a temperature of 200 °C followed by depolymerization. Zeta potential measurements showed that cop-MPP was anionic, whereas cop-MPH and MPN were non-ionic. Texture analysis revealed that work of adhesion (mN·s) for both cop-MPH (390 ± 0.0018) and MPN (304 ± 0.0024) enhanced the mucoadhesion compared with the un-processed hypromellose (300 ± 0.0019) and sodium carboxymethylcellulose (280 ± 0.0012), whereas cop-MPP (240 ± 0.0028) showed mucoadhesion similar to un-processed polyvinylpyrrolidone (250 ± 0.0022). In addition, the swelling studies showed enhancement in water absorbance for all co-processed excipients. Cytotoxicity against human cells revealed >99% of cell viability. These findings demonstrate that the co-processed biological macromolecule extracted from M. zapota seed could be further explored as an effective alternative drug delivery excipient for pharmaceutical applications.

Citing Articles

Development and Characterization of Trihexyphenidyl Orodispersible Minitablets: A Challenge to Fill the Therapeutic Gap in Neuropediatrics.

Olivera C, Boscolo O, Dobrecky C, Ortega C, Favier L, Cianchino V Pharmaceutics. 2025; 17(1).

PMID: 39861657 PMC: 11769368. DOI: 10.3390/pharmaceutics17010005.


Biogenic metallic nanoparticles: from green synthesis to clinical translation.

Shah D, Chorawala M, Mansuri M, Parekh P, Singh S, Prajapati B Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8603-8631.

PMID: 38935128 DOI: 10.1007/s00210-024-03236-y.


Nanofabrication of Losartan Potassium Sustained Release Floating Microspheres using Different Grades of Ethyl Cellulose and its Insight on Release Profiles.

Rajput T, Mohite P, Ghule S, Vinchurkar K, Singh S Curr Pharm Des. 2024; 30(28):2257-2265.

PMID: 38910484 DOI: 10.2174/0113816128309675240530060752.


Polymeric scaffold integrated with nanovesicle-entrapped curcuminoids for enhanced therapeutic efficacy.

Singh S, Supaweera N, Nwabor O, Yusakul G, Chaichompoo W, Suksamrarn A Nanomedicine (Lond). 2024; 19(14):1313-1329.

PMID: 38884141 PMC: 11285238. DOI: 10.1080/17435889.2024.2347823.


Agar Graft Modification with Acrylic and Methacrylic Acid for the Preparation of pH-Sensitive Nanogels for 5-Fluorouracil Delivery.

Ivanova I, Slavkova M, Popova T, Tzankov B, Stefanova D, Tzankova V Gels. 2024; 10(3).

PMID: 38534583 PMC: 10970384. DOI: 10.3390/gels10030165.